GENERAL
Zydus Lifesciences To Invest $20 Mn In Sri Lanka Pharma Production JV
Zydus Lifesciences Ltd, an innovation-driven global lifesciences company, has entered into a share subscription and shareholders’ agreement with Sunshine Healthcare Lanka Ltd to establish a pharmaceutical manufacturing facility in Sri Lanka with an investment of $20 million. The joint venture, Zydus Sunshine Lifesciences Pvt Ltd, will be set up at the Board of Investment zone […]
CW Bureau
·
Jun 26, 2026
GENERAL
Zydus, Torrent Partner To Co-Market Semaglutide Injection In India
Zydus Lifesciences and Torrent Pharmaceuticals have entered into a strategic licensing and supply agreement to co-market Semaglutide injection in India, marking a significant move in the fast-growing metabolic disorders segment. Under the agreement, Zydus will manufacture and supply the drug, while Torrent Pharma will hold semi-exclusive rights to co-market it under its own brand, Sembolic, […]
CW Bureau
·
Mar 18, 2026
GENERAL
Zydus’ Novel Single-Pen Device Set To Redefine Semaglutide Therapy
Zydus Lifesciences is preparing to launch Semaglutide injection under the brand names SEMAGLYN, MASHEMA and ALTERME, following the patent expiry of the molecule in the country. The Drug Controller General of India (DCGI) has already granted approval for the manufacturing and marketing of Semaglutide injection for the treatment of Type 2 Diabetes Mellitus and obesity, […]
CW Bureau
·
Feb 25, 2026
